You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1565-ESGO Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for metastatic ovarian cancer, fallopian tube cancer and primary peritoneal carcinoma: a systematic review by the UK PIPAC collaborative

Alerts

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-1565-ESGO Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for metastatic ovarian cancer, fallopian tube cancer and primary peritoneal carcinoma: a systematic review by the UK PIPAC collaborative
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address